Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer

This study has been completed.
Information provided by (Responsible Party):
Nippon Kayaku Co.,Ltd. Identifier:
First received: May 21, 2009
Last updated: February 12, 2015
Last verified: February 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2015
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)